Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H28N2O2 |
Molecular Weight | 340.4592 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCOCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=OXBBIHZWNDPBMQ-UHFFFAOYSA-N
InChI=1S/C21H28N2O2/c24-16-18-25-17-15-22-11-13-23(14-12-22)21(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-10,21,24H,11-18H2
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL231 Sources: https://www.medchemexpress.com/decloxizine.html |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Preliminary study of effects of decloxizine on air passage resistance in chronic bronchitis patients]. | 1968 Jul-Oct |
|
[Protective effect of decloxizine in relation to bronchospasm due to histamine]. | 1968 Jul-Oct |
|
Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine. | 1969 Jun |
|
Effect of decloxizine on histamine aerosol induced bronchoconstriction in the conscious guinea-pig. | 1969 Nov |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4395228
Curator's Comment: Intravenous route is possible
https://www.ncbi.nlm.nih.gov/pubmed/4904306
Three daily 50 mg doses of decloxizine proved sufficient to prevent asthma attacks and shortness of breath in the patients examined
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID40190777
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106665
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
2476
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
SUB06936MIG
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
100000083493
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
C76673
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
3733-63-9
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
919C49XAYD
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
289116
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY | |||
|
71135
Created by
admin on Fri Dec 15 16:33:18 GMT 2023 , Edited by admin on Fri Dec 15 16:33:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY